位置:首页 > 蛋白库 > RSH_BRUAB
RSH_BRUAB
ID   RSH_BRUAB               Reviewed;         750 AA.
AC   Q57E90;
DT   26-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   10-MAY-2005, sequence version 1.
DT   03-AUG-2022, entry version 104.
DE   RecName: Full=GTP pyrophosphokinase rsh;
DE            EC=2.7.6.5;
DE   AltName: Full=(p)ppGpp synthase;
DE   AltName: Full=ATP:GTP 3'-pyrophosphotransferase;
GN   Name=rsh; Synonyms=spoT; OrderedLocusNames=BruAb1_0669;
OS   Brucella abortus biovar 1 (strain 9-941).
OC   Bacteria; Proteobacteria; Alphaproteobacteria; Hyphomicrobiales;
OC   Brucellaceae; Brucella/Ochrobactrum group; Brucella.
OX   NCBI_TaxID=262698;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=9-941;
RX   PubMed=15805518; DOI=10.1128/jb.187.8.2715-2726.2005;
RA   Halling S.M., Peterson-Burch B.D., Bricker B.J., Zuerner R.L., Qing Z.,
RA   Li L.-L., Kapur V., Alt D.P., Olsen S.C.;
RT   "Completion of the genome sequence of Brucella abortus and comparison to
RT   the highly similar genomes of Brucella melitensis and Brucella suis.";
RL   J. Bacteriol. 187:2715-2726(2005).
RN   [2]
RP   FUNCTION IN ADAPTATION TO INTRACELLULAR REPLICATION, AND DISRUPTION
RP   PHENOTYPE.
RC   STRAIN=544 / Biovar 1;
RX   PubMed=15870469; DOI=10.1099/mic.0.27782-0;
RA   Kim S., Watanabe K., Suzuki H., Watarai M.;
RT   "Roles of Brucella abortus SpoT in morphological differentiation and
RT   intramacrophagic replication.";
RL   Microbiology 151:1607-1617(2005).
CC   -!- FUNCTION: Functions as a (p)ppGpp synthase. In eubacteria ppGpp
CC       (guanosine 3'-diphosphate 5'-diphosphate) is a mediator of the
CC       stringent response that coordinates a variety of cellular activities in
CC       response to changes in nutritional abundance. Plays a role in
CC       adaptation of Brucella to its intracellular host environment.
CC       {ECO:0000269|PubMed:15870469}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + GTP = AMP + guanosine 3'-diphosphate 5'-triphosphate;
CC         Xref=Rhea:RHEA:22088, ChEBI:CHEBI:30616, ChEBI:CHEBI:37565,
CC         ChEBI:CHEBI:142410, ChEBI:CHEBI:456215; EC=2.7.6.5;
CC   -!- DISRUPTION PHENOTYPE: Cells show morphological abnormalities such as
CC       branching and swelling forms. It does not grow in RPMI-1640 with or
CC       without 10% FBS. It shows decreased growth until 48 hours in RPMI-1640
CC       and stationary growth until 48 hours in RPMI-1640 with 10% FBS. It has
CC       the same ability as the wild-type to internalize at 0 minute but a
CC       lower rate of internalization at 30 minutes. It shows a lower rate of
CC       intracellular replication within macrophages than the wild-type. Its
CC       adherence is four times higher than that of the wild-type. It shows
CC       lower MICs than the wild-type for several antimicrobial agents such as
CC       penicillin G, methicillin, erythromycin and doxycycline. At ten days
CC       post infection the number of viable bacteria (disruption mutant) is
CC       markedly reduced compared to the wild-type.
CC       {ECO:0000269|PubMed:15870469}.
CC   -!- SIMILARITY: Belongs to the RelA/SpoT family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AE017223; AAX74044.1; -; Genomic_DNA.
DR   RefSeq; WP_002963796.1; NC_006932.1.
DR   AlphaFoldDB; Q57E90; -.
DR   SMR; Q57E90; -.
DR   EnsemblBacteria; AAX74044; AAX74044; BruAb1_0669.
DR   GeneID; 3787392; -.
DR   KEGG; bmb:BruAb1_0669; -.
DR   HOGENOM; CLU_012300_3_0_5; -.
DR   OMA; YKTIHTT; -.
DR   Proteomes; UP000000540; Chromosome I.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0008728; F:GTP diphosphokinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0016301; F:kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0015969; P:guanosine tetraphosphate metabolic process; IEA:InterPro.
DR   GO; GO:0016310; P:phosphorylation; IEA:UniProtKB-KW.
DR   CDD; cd00077; HDc; 1.
DR   CDD; cd05399; NT_Rel-Spo_like; 1.
DR   CDD; cd01668; TGS_RSH; 1.
DR   Gene3D; 3.10.20.30; -; 1.
DR   Gene3D; 3.30.460.10; -; 1.
DR   InterPro; IPR045865; ACT-like_dom_sf.
DR   InterPro; IPR002912; ACT_dom.
DR   InterPro; IPR012675; Beta-grasp_dom_sf.
DR   InterPro; IPR003607; HD/PDEase_dom.
DR   InterPro; IPR006674; HD_domain.
DR   InterPro; IPR043519; NT_sf.
DR   InterPro; IPR004811; RelA/Spo_fam.
DR   InterPro; IPR045600; RelA/SpoT_AH_RIS.
DR   InterPro; IPR007685; RelA_SpoT.
DR   InterPro; IPR004095; TGS.
DR   InterPro; IPR012676; TGS-like.
DR   InterPro; IPR033655; TGS_RelA/SpoT.
DR   Pfam; PF13291; ACT_4; 1.
DR   Pfam; PF19296; DUF5913; 1.
DR   Pfam; PF04607; RelA_SpoT; 1.
DR   Pfam; PF02824; TGS; 1.
DR   SMART; SM00471; HDc; 1.
DR   SMART; SM00954; RelA_SpoT; 1.
DR   SUPFAM; SSF55021; SSF55021; 1.
DR   SUPFAM; SSF81271; SSF81271; 1.
DR   SUPFAM; SSF81301; SSF81301; 1.
DR   TIGRFAMs; TIGR00691; spoT_relA; 1.
DR   PROSITE; PS51671; ACT; 1.
DR   PROSITE; PS51831; HD; 1.
DR   PROSITE; PS51880; TGS; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; GTP-binding; Kinase; Nucleotide-binding; Transferase.
FT   CHAIN           1..750
FT                   /note="GTP pyrophosphokinase rsh"
FT                   /id="PRO_0000322563"
FT   DOMAIN          45..144
FT                   /note="HD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01175"
FT   DOMAIN          390..451
FT                   /note="TGS"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01228"
FT   DOMAIN          676..750
FT                   /note="ACT"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01007"
FT   REGION          587..613
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   750 AA;  83856 MW;  4836EEECB0E52495 CRC64;
     MMRQYELVER VQRYKPDVNE ALLNKAYVYA MQKHGSQKRA SGDPYFSHPL EVAAILTDMH
     LDEATIAIAL LHDTIEDTTA TRQEIDQLFG PEIGKLVEGL TKLKKLDLVS KKAVQAENLR
     KLLLAISEDV RVLLVKLADR LHNMRTLGVM REDKRLRIAE ETMDIYAPLA GRMGMQDMRE
     ELEELAFRYI NPDAWRAVTD RLAELLEKNR GLLQKIETDL SEIFEKNGIK ASVKSRQKKP
     WSVFRKMETK GLSFEQLSDI FGFRVMVDTV QDCYRALGLI HTTWSMVPGR FKDYISTPKQ
     NDYRSIHTTI IGPSRQRIEL QIRTREMDEI AEFGVAAHSI YKDRGSANNP HKISTETNAY
     AWLRQTIEQL SEGDNPEEFL EHTKLELFQD QVFCFTPKGR LIALPRGATP IDFAYAVHTD
     IGDSCVGAKV NGRIMPLMTE LKNGDEVDII RSKAQVPPAA WESLVATGKA RAAIRRATRS
     AVRKQYSGLG MRILERAFER AGKPFSKDIL KPGLPRLARK DVEDVLAAVG RGELPSADVV
     KAVYPDYQDT RVTTQNNPAK AGEKGWFNIQ NAAGMIFKVP EGGEGAAAKV DPAATTPKPG
     KRALPIRGTN PDLPVRFAPE GAVPGDRIVG ILQPGAGITI YPIQSPALTA YDDQPERWID
     VRWDIDDQMS ERFPARISVS AINSPGSLAE IAQIAAANDA NIHNLSMART APDFTEMIID
     VEVWDLKHLN RIISQLKESA SVSSAKRVNG
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024